Skip to main content
SpringerLink
Log in

Le Ganoderma lucidum: accompagnement cancérologique, lutte antivirale, lutte contre l’inflammation ou contre le syndrome métabolique

Ganoderma lucidum, the most eclectic mushroom: useful in oncology or against virus, inflammation or metabolic diseases.

  • Formation Continue
  • Mycothérapie
  • Published:
Phytothérapie

Résumé

Le Ganoderma lucidum (GL) est un agent apoptoptique incontournable dans la lutte antitumorale. Il agit par de nombreuses voies (caspases, p38 mitogen-activated kinase [p38 MAPK], NF-kappaB, Akt/Erk, Bcl2, VEGF) et est utilisé avec succès dans les cancers digestifs, mammaires, prostatiques et les leucémies-lymphomes. Il possède des propriétés antivirales contre l’herpès ou l’hépatite B. C’est un excellent néphrohépatoprotecteur; propriété précieuse chez les patients qui subissent une chimiothérapie. Il s’impose dans le traitement du syndrome métabolique, grâce à ses effets sur le cholestérol, l’HTA ou la glycémie. Par ses propriétés antalgiques ou anti-inflammatoires dénuées d’effet indésirable, il soulage les patients atteints d’arthrose ou d’arthrite.

Abstract

Ganoderma lucidum (GL) is an essential apoptotic agent against tumoral cells which action implies several pathways (caspases, p38 MAPK, NF-kappaB, Akt/Erk, Bcl2, VEGF). It is appropriately recommended in digestive, breast, prostatic or leucemic cancers. It possesses anti-viral properties against herpes or hepatitis B. Its excellent nephro-hepatoprotective profile enables to protect patients undergoing chemotherapy and receiving many medications. Because of its actions against hypertension, diabetes, cholesterol, it could be used in metabolic diseases. It is an anti-inflammatory and antalgic agent devoided of noxious effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliographie

  1. Ahn GO, Brown JM (2008) Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 3: 193–205

    Article  CAS  Google Scholar 

  2. Bao XF, Zhen Y, Ruan L, Fang JN (2002) Purification, characterization, and modification of T lymphocyte-stimulating polysaccharide from spores of Ganoderma lucidum. Chem Pharm Bull (Tokyo) 5: 623–629

    Article  Google Scholar 

  3. Berger A, Rein D, Kratky E, et al. (2004) Cholesterol-lowering properties of GL in vitro, ex vivo, and in hamsters and minipigs. Lipids Health Dis 18: 3:2

    Google Scholar 

  4. Bergers G, Brekken R, McMahon G, et al. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 10: 737–744

    Google Scholar 

  5. Calviño E, Manjón JL, Sancho P, et al. (2010) GLinduced apoptosis in NB4 human leukemia cells: involvement of Akt and Erk. J Ethnopharmacol 1: 71–78

    Article  Google Scholar 

  6. Calviño E, Pajuelo L, de Eribe Casas JA, et al. (2010) Cytotoxic action of GLon interleukin-3 dependent lymphoma DA-1 cells: involvement of apoptosis proteins. Phytother Res

  7. Cao QZ, Lin ZB (2006) Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci 13: 1457–1463

    Article  CAS  Google Scholar 

  8. Chen NH, Liu JW, Zhong JJ (2008) Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression. Pharmacol Sci 2: 212–216

    Article  CAS  Google Scholar 

  9. Chen NH, Liu JW, Zhong JJ (2010) Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression. Pharmacol Rep 1: 150–163

    Google Scholar 

  10. Chuang MH, Chiou SH, Huang CH, et al. (2009) The lifespan-promoting effect of acetic acid and Reishi polysaccharide. Bioorg Med Chem 22: 7831–7840

    Article  CAS  Google Scholar 

  11. Czop JK, Austen KF (1985) A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. Immunol 134: 2588–2593

    CAS  Google Scholar 

  12. Dudhgaonkar S, Thyagarajan A, Sliva D (2009) Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. Int Immunopharmacol 11: 1272–1280

    Article  CAS  Google Scholar 

  13. El-Mekkawy S, Meselhy MR, Nakamura N, et al. (1998) Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry 6: 1651–1657

    Article  Google Scholar 

  14. Eo SK, Kim YS, Lee CK, Han SS (1999) Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J Ethnopharmacol 68: 129–136

    Article  CAS  PubMed  Google Scholar 

  15. Fujita R, Liu J, Shimizu K, et al. (2005) Anti-androgenic activities of Ganoderma lucidum. J Ethnopharmacol 1: 107–112

    Article  Google Scholar 

  16. Fukuzawa M, Yamaguchi R, Hide I, et al. (2008) Possible involvement of long chain fatty acids in the spores of Ganoderma lucidum (Reishi Houshi) to its anti-tumor activity. Biol Pharm Bull 10: 1933–1937

    Article  Google Scholar 

  17. Futrakul N, Boonyen M, Patumraj S, et al. (2003) Treatment of glomerular endothelial dysfunction in steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators. Clin Hemorheol Microcirc 3–4: 205–210

    Google Scholar 

  18. Gao Y, Zhou S, Jiang W, et al. (2003) Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 32: 201–215

    Article  PubMed  Google Scholar 

  19. Gao Y, Zhou S, Wen J, et al. (2002) Mechanism of the anti-ulcerogenic effect of Ganoderma lucidum polysaccharides on indomethacin-induced lesions in the rat. Life Sci 72: 731–745

    Article  CAS  PubMed  Google Scholar 

  20. Ghafar MA, Golliday E, Bingham J, et al. (2002) Regression of prostate cancer following administration of Genistein Combined Polysaccharide (GCP), a nutritional supplement: a case report. J Altern Complement Med 4: 493–497

    Article  Google Scholar 

  21. Haak-Frendscho M, Kino K, Sone T, Jardieu P (1993) Ling Zhi-8: a novel T cell mitogen induces cytokine production and upregulation of ICAM-1 expression. Cell Immunol 1: 101–113

    Article  Google Scholar 

  22. Hajjaj H, Macé C, Roberts M, et al. (2005) Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors. Appl Environ Microbiol 7: 3653–3658

    Article  CAS  Google Scholar 

  23. He CY, Li WD, Guo SX, et al. (2006) Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice. J Asian Nat Prod Res 8: 705–711

    Article  CAS  PubMed  Google Scholar 

  24. Hikino H, Ishiyama M, Suzuki Y, Kono C (1989) Mechanism of hypoglycemic activity of Ganoderma B: A glycan of Ganoderma lucidum fruit bodies. Planta Medica 55: 423–428

    Article  CAS  PubMed  Google Scholar 

  25. Hong KJ, Dunn DM, Shen CL, Pence BC (2004) Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colonic carcinoma cells. Phytother Res 9: 768–770

    Article  CAS  Google Scholar 

  26. Hsu HY, Hua KF, Wu WC, et al. (2008) Reishi immuno-modulation protein induces interleukin-2 expression via protein kinase-dependent signaling pathways within human T cells. J Cell Physiol 1: 15–26

    Article  CAS  Google Scholar 

  27. Hsu CC, Lin KY, Wang ZH, et al. (2008) Preventive effect of Ganoderma amboinense on acetaminophen-induced acute liver injury. Phytomedicine [Epub ahead of print]

  28. Hsu SC, Ou CC, Chuang TC, et al. (2009) Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo. Cancer Lett 1: 108–116

    Article  CAS  Google Scholar 

  29. Hu H, Ahn NS, Yang X, et al. (2002) Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 102: 250–253

    Article  CAS  PubMed  Google Scholar 

  30. Huang SQ, Ning ZX (2010) Extraction of polysaccharide from Ganoderma lucidum and its immune enhancement activity. Int J Biol Macromol [Epub ahead of print]

  31. Iwatsuki K, Akihisa T, Tokuda H, et al. (2003) Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation. J Nat Prod 12: 1582–1585

    Article  CAS  Google Scholar 

  32. Jiang J, Grieb B, Thyagarajan A, Sliva D (2008) Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int J Mol Med 5: 577–574

    Google Scholar 

  33. Jiang J, Slivova V, Sliva D (2006) Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Int J Oncol 3: 695–703

    Google Scholar 

  34. Jiang J, Slivova V, Valachovicova T, et al. (2004) Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol 5: 1093–1099

    Google Scholar 

  35. Jiménez-Medina E, Berruguilla E, Romero I, et al. (2008) The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis. BMC Cancer 8:78

    Article  PubMed  CAS  Google Scholar 

  36. Johnston N (2005) Medicinal mushroom cuts off prostate cancer cells’ blood supply. Drug Discov Today 23–24: 1584

    Article  Google Scholar 

  37. Jung K, Kim IH, Han D (2004) Effect of medicinal plant extracts on forced swimming capacity in mice. J Ethnopharmacol 1: 75–81

    Article  Google Scholar 

  38. Kim HS, Kacew S, Lee BM (1999) In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis miller, Lentinus edodes, Ganoderma lucidum and Coriolis versicolor). Carcinogenesis 8: 1637–1640

    Article  Google Scholar 

  39. Kim KC, Kim JS, Son JK, Kim IG (2007) Enhanced induction of mitochondrial damage and apoptosis in human leukemia HL-60 cells by the Ganoderma lucidum and Duchesnea chrysantha extracts. Cancer Lett 1–2: 210–217

    Article  CAS  Google Scholar 

  40. Kim DH, Shim SB, Kim NJ, Jang IS (1999) Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol Pharm Bull 2: 162–164

    Google Scholar 

  41. Kimberly KB, Heitmeyer SA, Hookfin EB, et al. (2008) P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis. J Inflamm 5:22doi:10.1186/1476

    Article  CAS  Google Scholar 

  42. Kimura Y, Taniguchi M, Baba K (2002) Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res 6A:3309–1862

    Google Scholar 

  43. Kino K, Mizumoto K, Sone T, et al. (1990) An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice. Diabetologia 12: 713–718

    Article  Google Scholar 

  44. Kino K, Sone T, Watanabe J, et al. (1991) Immunomodulator, LZ-8, prevents antibody production in mice. Int J Immunopharmacol 8: 1109–1115

    Google Scholar 

  45. Kino K, Yamashita A, Yamaoka K, et al. (1989) Isolation and characterization of a new immunomodulatory protein, Ling Zhi-8 (LZ-8), from Ganoderma lucidium. J Biol Chem 1: 472–478

    Google Scholar 

  46. Komoda Y, Shimizu M, Sonoda Y, Sato Y (1989) Ganoderic acid and its derivatives as cholesterol synthesis inhibitors.Chem Pharm Bull (Tokyo) 2: 531–533

    Google Scholar 

  47. Koyama K, Imaizumi T, Akiba M, et al. (1997) Antinociceptive components of Ganoderma lucidum. Planta Med 3: 224–227

    Article  Google Scholar 

  48. Lai KN, Chan LY, Tang SC, Leung JC (2006) Ganoderma extract prevents albumin-induced oxidative damage and chemokines synthesis in cultured human proximal tubular epithelial cells. Nephrol Dial Transplant 5: 1188–1197

    Article  Google Scholar 

  49. Lakshmi B, Ajith TA, Sheena N, et al. (2003) Antiperoxidative, anti-inflammatory, and antimutagenic activities of ethanol extract of the mycelium of Ganoderma lucidum occurring in South India. Teratog Carcinog Mutagen Suppl 1:85–97

    Article  CAS  Google Scholar 

  50. Lee I, Kim H, Youn U, et al. (2010) Effect of Lanostane Triterpenes from the Fruiting Bodies of Ganoderma lucidum on Adipocyte Differentiation in 3T3-L1 Cells. Planta Med [Epub ahead of print]

  51. Lee SH, Lillehoj HS, Hong YH, et al. (2010) In vitro effects of plant and mushroom extracts on immunological function of chicken lymphocytes and macrophages. Br Poult Sci 2: 213–221

    Article  CAS  Google Scholar 

  52. Lee SY, Rhee HM (1990) Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem Pharm Bull (Tokyo) 5: 1359–1364

    Google Scholar 

  53. Lei LS, Lin ZB (1993) Effects of Ganoderma polysaccharides on the activity of DNA polymerase alpha of splenocytes and immune function in aged mice [Article in Chinese]. Yao Xue Xue Bao 8: 577–582

    Google Scholar 

  54. Li CH, Chen PY, Chang UM, et al. (2005) Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci 3: 252–265

    Article  CAS  Google Scholar 

  55. Li WJ, Nie SP, Chen Y, et al. (2010) Ganoderma atrum polysaccharide protects cardiomyocytes against anoxia/reoxygenation-induced oxidative stress by mitochondrial pathway. J Cell Biochem 1: 191–200

    Google Scholar 

  56. Li YQ, Wang SF (2006) Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnol Lett 11: 837–841

    Article  CAS  Google Scholar 

  57. Li Khva Ren, Vasil’ev AV, Orekhov AN, et al. (1989) [Anti-atherosclerotic properties of higher mushrooms (a clinico-experimental investigation)] [Article in Russian]. Vopr Pitan 1: 16–19

    Google Scholar 

  58. Lin JM, Lin CC, Chen MF, et al. (1995) Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neo-japonicum. J Ethnopharmacol 1: 33–41

    Article  Google Scholar 

  59. Liu J, Kurashiki K, Shimizu K, Kondo R (2006) Structure-activity relationship for inhibition of 5alpha-reductase by triterpenoids isolated from Ganoderma lucidum. Bioorg Med Chem 24: 8654–8660

    Article  CAS  Google Scholar 

  60. Liu J, Shiono J, Shimizu K, Kondo R (2010) Ganoderic acids from Ganoderma lucidum: inhibitory activity of osteoclastic differentiation and structural criteria. Planta Med 2: 137–139

    Article  CAS  Google Scholar 

  61. Liu J, Tamura S, Kurashiki K, Shimizu K, et al. (2009) Anti-androgen effects of extracts and compounds from Ganoderma lucidum. Chem Biodivers 2: 231–243

    Article  Google Scholar 

  62. Liu J, Yang F, Ye LB, et al. (2004) Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. J Ethnopharmacol 2-3: 265–272

    Article  CAS  Google Scholar 

  63. Lu H, Kyo E, Uesaka T, et al. (2002) Prevention of development of N,N’-dimethylhydrazine-induced colon tumors by a water-soluble extract from cultured medium of Ganoderma lucidum (Reishi) mycelia in male ICR mice. Int J Mol Med 9: 113–117

    PubMed  Google Scholar 

  64. Lu QY, Sartippour MR, Brooks MN, et al. (2004) Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol Rep 12: 659–662

    PubMed  Google Scholar 

  65. Maruyama H, Yamazaki K, Murofushi S, et al. (1989) Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst. J Pharmacobiodyn 12(2): 118–123

    CAS  PubMed  Google Scholar 

  66. Min BS, Nakamura N, Miyashiro H, et al. (1998) Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull (Tokyo) 10: 1607–1612

    Google Scholar 

  67. Miyamoto I, Liu J, Shimizu K, et al. (2009) Regulation of osteoclastogenesis by ganoderic acid DM isolated from Ganoderma lucidum. Eur J Pharmacol 1: 1–7

    Article  CAS  Google Scholar 

  68. Mizushina Y, Hanashima L, Yamaguchi T, et al. (1998) A mushroom fruiting body-inducing substance inhibits activities of replicative DNA polymerases. Biochem Biophys Res Commun 1: 17–22

    Article  Google Scholar 

  69. Morigiwa A, Kitabatake K, Fujimoto Y, Ikekawa K (1986). Angiotensin converting enzyme-inhibiting triterpenes from Ganoderma lucidum. Chem Phar Bull 34: 3025–308

    CAS  Google Scholar 

  70. Nonaka Y, Ishibashi H, Nakai M, et al. (2008) Effects of the antlered form of Ganoderma lucidum on tumor growth and metastasis in cyclophosphamide-treated mice. Biosci Biotechnol Biochem 6: 1399–1408

    Article  CAS  Google Scholar 

  71. Oka S, Tanaka S, Yoshida S, et al. (2010) A water-soluble extract from culture medium of Ganoderma lucidum mycelia suppresses the development of colorectal adenomas. Hiroshima J Med Sci 1: 1–6

    Google Scholar 

  72. Rubel R, Dalla Santa HS, Bonatto SJ, et al. (2010) Medicinal mushroom Ganoderma lucidum (Leyss: Fr) Karst. triggers immunomodulatory effects and reduces nitric oxide synthesis in mice. J Med Food 1: 142–148

    Article  CAS  Google Scholar 

  73. Sadava D, Still DW, Mudry RR, Kane SE (2009) Effect of Ganoderma on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells. Cancer Lett 2: 182–189

    Article  CAS  Google Scholar 

  74. Sanodiya BS, Thakur GS, Baghel RK, et al. (2009) Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol 8: 717–742

    Article  Google Scholar 

  75. Sato N, Zhang Q, Ma CM, Hattori M (2009) Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense. Chem Pharm Bull (Tokyo) 10: 1076–1080

    Article  Google Scholar 

  76. Sasaki T, Arai Y, Ikekawa T, et al. (1971) Antitumor polysaccharides from some polyporaceae, Ganoderma applanatum (Pers.) Pat and Phellinus linteus (Berk. et Curt) Aoshima. Chem Pharm Bull (Tokyo) 4: 821–826

    Google Scholar 

  77. Seto SW, Lam TY, Tam HL, et al. (2009) Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine 5: 426–436

    Article  Google Scholar 

  78. Shi Y, Sun J, He H, et al. (2008) Hepatoprotective effects of Ganoderma lucidum peptides against D-galactosamine-induced liver injury in mice. J Ethnopharmacol 3: 415–419

    Article  CAS  Google Scholar 

  79. Shieh YH, Liu CF, Huang YK, et al. (2001) Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice. Am J Chin Med 29: 501–507

    Article  CAS  PubMed  Google Scholar 

  80. Sliva D (2003) Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther 4: 358–364

    Article  Google Scholar 

  81. Sliva D, Labarrere C, Slivova V, et al. (2002) Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 4: 603–612

    Article  CAS  Google Scholar 

  82. Sliva D, Sedlak M, Slivova V, et al. (2003) Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Complement Med 4: 491–497

    Article  Google Scholar 

  83. Stanley G, Harvey K, Slivova V, et al. (2005) Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem Biophys Res Commun 330(1): 46–52

    Article  CAS  PubMed  Google Scholar 

  84. Sze DM, Chan GC (2009) Supplements for immune enhancement in hematologic malignancies. Hematology Am Soc Hematol Educ Program 313–319

  85. Tanaka S, Ko K, Kino K, et al. (1989) Complete amino acid sequence of an immunomodulatory protein, Ling Zhi-8 (LZ-8). An immunomodulator from a fungus, Ganoderma lucidium, having similarity to immunoglobulin variable regions. J Biol Chem 28: 16372–16377

    Google Scholar 

  86. Tang W, Gao Y, Chen G, et al. (2005) A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. J Med Food 1: 53–58

    Article  Google Scholar 

  87. Tang W, Liu JW, Zhao WM, et al. (2006) Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci 3: 205–211

    Article  CAS  Google Scholar 

  88. Thyagarajan A, Jedinak A, Nguyen H, et al. (2010) Triterpenes from Ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK). Nutr Cancer 5: 630–640

    Article  CAS  Google Scholar 

  89. Thyagarajan A, Jiang J, Hopf A, et al. (2006) Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Int J Mol Med 4: 657–664

    Google Scholar 

  90. Thyagarajan A, Zhu J, Sliva D (2007) Combined effect of green tea and Ganoderma lucidum on invasive behavior of breast cancer cells. Int J Oncol 4: 963–969

    Google Scholar 

  91. van der Hem LG, van der Vliet JA, Bocken CF, et al. (1994) Prolongation of allograft survival with Ling Zhi-8, a new immunosuppressive drug. Transplant Proc 2: 74

    Google Scholar 

  92. van der Hem LG, van der Vliet JA, Bocken CF, et al. (1995) Ling Zhi-8: studies of a new immunomodulating agent. Transplantation 5: 438–443

    Google Scholar 

  93. van der Hem LG, van der Vliet JA, Kino K, et al. (1996) Ling-Zhi-8: a fungal protein with immunomodulatory effects. Transplant Proc 2: 958–959

    Google Scholar 

  94. Wan F, Huang D (1992) Anti-inflammatory and analgesic actions of artificial and fermentative Ganoderma sinense (AFGS) Zhongguo Zhong Yao Za Zhi 10: 619–622, 640

    Google Scholar 

  95. Wang GJ, Huang YJ, Chen DH, Lin YL (2009) Ganoderma lucidum extract attenuates the proliferation of hepatic stellate cells by blocking the PDGF receptor. Phytother Res 6: 833–839

    Article  CAS  Google Scholar 

  96. Wang G, Zhao J, Liu J, et al. (2007) Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo. Int Immunopharmacol 6: 864–870

    Article  CAS  Google Scholar 

  97. Wen XY, Wu SY, Xu W, et al. (2007) Inhibitory effect of polysaccharides on the six-alpha-helix bundle formation of HIV gp41 protein. Nan Fang Yi Ke Da Xue Xue Bao 10: 1498–500 [Chinese]

    Google Scholar 

  98. Weng CJ, Chau CF, Yen GC, et al. (2009) Inhibitory effects of Ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models. J Agric Food Chem 11: 5049–5057

    Article  CAS  Google Scholar 

  99. Weng CJ, Yen GC (2010) The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metastasis 5: 361–369

    Article  Google Scholar 

  100. Weng Y, Xiang L, Matsuura A, et al. (2010) Ganodermasides A and B, two novel anti-aging ergosterols from spores of a medicinal mushroom Ganoderma lucidum on yeast via UTH1 gene. Bioorg Med Chem 3: 999–1002

    Article  CAS  Google Scholar 

  101. Wong CK, Bao YX, Wong EL, et al. (2005) Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med 3: 381–395

    Google Scholar 

  102. Wu YW, Fang HL, Lin WC (2010) Post-treatment of Ganoderma lucidum reduced liver fibrosis induced by thioacetamide in mice. Phytother Res 4: 494–499

    Google Scholar 

  103. Yang XJ, Liu J, Ye LB, et al. (2006) In vitro and in vivo protective effects of proteoglycan isolated from mycelia of Ganoderma lucidum on carbon tetrachloride-induced liver injury. World J Gastroenterol 9: 1379–1385

    Google Scholar 

  104. Yang Q, Wang S, Xie Y, et al. (2010) HPLC analysis of Ganoderma lucidum polysaccharides and its effect on antioxidant enzymes activity and Bax, Bcl-2 expression. Int J Biol Macromol 2: 167–172

    Article  CAS  Google Scholar 

  105. Zaidman BZ, Wasser SP, Nevo E, Mahajna J (2007) Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells. Int J Oncol 4: 959–967

    Google Scholar 

  106. Zaidman BZ, Wasser SP, Nevo E, Mahajna J (2008) Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells. Mol Biol Rep 2: 107–117

    Article  CAS  Google Scholar 

  107. Zhang HN, He JH, Yuan L, et al. (2003) In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage. Life Sci 73: 2307–2319

    Article  CAS  PubMed  Google Scholar 

  108. Zhang GL, Wang YH, Ni W, et al. (2002) Hepatoprotective role of Ganodermma lucidum polysaccharide against BCG-induced immune liver injury in mice. World J Gastroenterol 8: 728–723

    CAS  PubMed  Google Scholar 

  109. Zhang Q, Andoh T, Konno M, et al. (2010) Inhibitory effect of methanol extract of Ganoderma lucidum on acute itch-associated responses in mice. Biol Pharm Bull 5: 909–911

    Article  Google Scholar 

  110. Zhang ZG, Wang C, Li L (2009) Effects of Gadol and Ganoderma spores on the adiponectin signal pathway in hypertrophic myocardium of spontaneous hypertensive rats. [Article in Chinese] Zhongguo Zhong Xi Yi Jie He Za Zhi 3: 233–237

    Google Scholar 

  111. Zhou GQ, Zhao HY, Lu C (2009) Effect of Ganoderma lucidum polysaccharides on intestinal mucosal immune system in H22 liver cancer bearing mice. [Article in Chinese] Zhongguo Zhong Xi Yi Jie He Za Zhi 4: 335–339

    Google Scholar 

  112. Zhou ZY, Tang YP, Xiang J, et al. (2010) Neuroprotective effects of water-soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. J Ethnopharmacol 131(1): 154–164

    Article  CAS  PubMed  Google Scholar 

  113. Zhu XL, Lin ZB (2005) Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells. Acta Pharmacol Sin 9: 1130–1137

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Médecine Information Éducation, 40, rue du Dr Roux, F-51350, Cormontreuil, France

    B. Donatini

Authors
  1. B. Donatini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Donatini.

About this article

Cite this article

Donatini, B. Le Ganoderma lucidum: accompagnement cancérologique, lutte antivirale, lutte contre l’inflammation ou contre le syndrome métabolique. Phytothérapie 8, 307–312 (2010). https://doi.org/10.1007/s10298-010-0580-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10298-010-0580-7

Mots clés

Keywords

Search

Navigation